Back to Rankings

RCUS

Arcus BiosciencesC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
RCUS vs peer average
50/100
RCUS vs. peer average (C vs. C)
Grade spread
B 3 · C 5 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

MRK is the first available peer comparator.

Merck is the closest mechanism benchmark because WELIREG is the approved HIF-2alpha reference in RCC, so Arcus must show casdatifan data strong enough to support a differentiated frontline and sequencing story.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMRKMerck
RCUS
Arcus Biosciences
MRK
Merck
Grade
C
C
Momentum
77
41
Value
41
64
Sentiment
44
43
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs MRK

RCUS / MRK
Grade Position
In line
RCUS vs. peer average (C vs. C)
50/100
Momentum
77
RCUS
Value
41
MRK
Sentiment
44
RCUS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RCUS
1
MRK
MRK
C
60/100
Even
2
EXEL
EXEL
C
60/100
Even
3
OGN
Organon & Co Common
B
80/100
-1
4
TLX
Telix Pharmaceuticals Ltd ADR
C
60/100
Even
5
ALMS
Alumis Inc Common
B
80/100
-1
MRK is the first peer returned for this comparison set.